At-home testing breakthrough: Self-collected fingerprick blood samples matched clinic results for Alzheimer’s biomarkers, offering a potential scalable screening tool. Biomarkers and cognition: ...

New home test: A self-collected fingerprick blood test accurately measures Alzheimer’s-related biomarkers, matching clinic-based methods. Early risk spotting: Combined with online cognitive tests, it ...

Finger-prick blood test alongside online thinking test could flag people with early memory problems which could become ...

The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...

That blood test your doctor suggested to check for Alzheimer’s? It might be giving dramatically different results depending on your race. While these tests promise earlier detection of a devastating ...

Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A major Alzheimer’s ...

The earlier Alzheimer’s disease can be diagnosed, the better the outcomes; however, it can be hard to diagnose the disease in its earliest stages. The United States Food and Drug Administration ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...